20 August 2019 - First Order for VISITECT® CD4 Advanced Disease Test
Tue, 20 Aug 2019 10:19:00 GMT
We are excited to announce that we have received our first purchase order for 20,000 units of its VISITECT® CD4 Advanced Disease test from our partner company in Zimbabwe. Whilst the VISITECT® CD4 Advanced Disease test is currently undergoing review by the UNITAID-funded Expert Review Panel for Diagnostics (ERPD), the order from Zimbabwe is not contingent upon conclusion of the ERPD process as this order will supply into B2B marketing channels, rather than NGOs.
Read the full announcement here
Comments are closed for this post, but if you have spotted an error or have additional info that you think should be in this post, feel free to contact us.